‘Chinese medicine getting popular’ among non-Chinese’

by Lee Ya Yun, reporters@theborneopost.com. Posted on November 11, 2012, Sunday

CONGRESS OF CHINESE MEDICINE: She (left) and Li at the press conference.

KUCHING: The effort to integrate Chinese medicine into mainstream health system in non-Chinese majority countries is gaining momentum in recent years, said the World Federation of Chinese Medicine Societies (WFCMS) chairwoman She Jing yesterday.

She pointed out that the positive development could be seen from a resolution that was passed in a recent meeting of World Health Organisation (WHO) in urging its member states to include traditional medicine into their national health system as well as the significant number of countries practising the Chinese medicine.

There are over 160 countries in the world practising Chinese medicine. Among the popular methods are acupuncture and massage. In America, acupuncture is even covered in insurance policy, she told a press conference prior to the opening of the 9th World Congress of Chinese Medicine at the Borneo Convention Centre Kuching (BCCK) here.

She explained that Chinese medicine, which emphasises on the balance between the human body and the environment, is getting appreciated by many non-Chinese who are seeking a healthy lifestyle.

WFCMS vice-chairman and secretary-general Prof Li Zhen Ji, who was also present at the news conference, added that Chinese medicine with its complete system and proven medical record is the main reason the traditional medicine is being accepted by non-Chinese.

He claimed that over 10,000 non-Chinese have completed their studies in Chinese medicine in China, out of which over two thousand are pursuing masters and PhD degrees.

There are over 90 countries in the world collaborating with the Chinese government in the study of Chinese medicine. This figure is solid proof that Chinese medicine is widely recognised in foreign countries.

In Malaysia, the Traditional and Complementary (TCM) Bill 2012 was tabled for first reading in the Dewan Rakyat on June 27.

Visit link:

‘Chinese medicine getting popular’ among non-Chinese’

Regenerative medicine raises hope

By Jeff Hansel The Post-Bulletin, Rochester MN

Even as regenerative medicine emerges as a new hope for many, doctors caution that it takes time to get a new discovery from the research lab to patient treatment.

As an example, one type of regenerative medicine, treatment of blood cancer disorders, has taken about 50 years to develop, said Mayo Clinic heart specialist Dr. Andre Terzic,director of Mayo's regenerative medicine center.

"We want to make sure that we are not creating a hype in the society but that we are really offering hope for patients, and ultimately definitive solutions," he said.

Yet it might be hard for people awaiting cures to contain their excitement.

"It has clearly gone from science fiction into rigorous science, and now from science it's going into practice," Terzic said. "It's not yet a broadly-offered servicebut it's in the phase of rigorous clinical trials."

Dr. Stephen Russell, Mayo Clinic's associate director for translation, says"we can't just take what we did in the mouse and apply it in the clinic."

"What we have to do is we have to develop a clinical protocol, we have to scale up the manufacture of the product that we're going to use, which may involve the scaled culturing of cells from a patient," he said.

Human research studies must pass muster from the Institutional Review Board at Mayo as well as from the FDA.

"That process with your foot hard on the accelerator is probably a two- to three-year process," Russell said.

Read this article:

Regenerative medicine raises hope

BG Medicine Announces Data Analyses Presented at American Heart Association Meeting

WALTHAM, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, today announced that results of retrospective analyses of the BioImage Study cohort were presented this week at the American Heart Association (AHA) Scientific Sessions 2012 in Los Angeles. These presentations resulted from research sponsored by the company and included data on the CardioSCORE(TM) test, a proprietary blood test currently being developed by the company.

In four scientific presentations, investigators from the Mt. Sinai School of Medicine and the Baptist Hospital of Miami jointly presented the following findings:

"BioImage Study: Value of Novel Biomarker Panel (CardioSCORE) in Predicting Major Adverse Cardiovascular Events among those with Absence of Coronary Calcification" assessed the value of the CardioSCORE test for predicting near-term cardiovascular risk among the 1,832 study participants who were found to be free of coronary arterial calcification as determined by computed tomography. For this group, otherwise assessed to be at low risk for cardiovascular events, investigators reported that elevated CardioSCORE test results were associated with a significantly increased risk of major cardiovascular events, including heart attack and ischemic stroke, in the near-term follow-up period of 2.5 years.

"BioImage Study: Reclassification and Discrimination by Novel Biomarker Panel (CardioSCORE), Coronary Calcium Score, Carotid Intima-Media Thickness & Plaque Burden in Asymptomatic Individuals" compared the predictive power of the CardioSCORE test to three atherosclerosis imaging modalities including coronary artery calcium evaluation by computed tomography, ultrasound carotid intima-media thickness assessment, and ultrasound carotid atherosclerotic plaque quantification. Across the entire study cohort, investigators reported that the CardioSCORE test yielded near-term cardiovascular event prediction significantly better than conventional ultrasound imaging methodologies, and was of comparable predictive power as coronary artery calcium evaluation.

"BioImage Study: Novel Biomarker Panel (CardioSCORE) for the Prediction of First Major Cardiovascular Events across the Full Range of Framingham Risk Scores" assessed the extent of the additive predictive value of the CardioSCORE test to traditional risk factor scoring as aggregated in the Framingham Risk Score, in 6,600 study participants. Investigators reported that the addition of the CardioSCORE test to the Framingham Risk Score significantly increased the accuracy with which individuals at high risk for near-term events were correctly identified, particularly within the low and intermediate risk categories.

"BioImage Study: Combined Use of Novel Biomarker Panel (CardioSCORE) and Computed Tomography Coronary Calcium Scores in Predicting Major Adverse Cardiovascular Events" assessed 5,763 study participants to determine the extent of the additive predictive value of the CardioSCORE Test to coronary artery calcium scoring by computed tomography. Investigators reported that the addition of CardioSCORE test results to coronary artery calcium scoring significantly increased the accuracy with which individuals at high risk for near-term events were correctly identified across all levels of coronary calcification.

"These results suggest that the CardioSCORE test has the significant potential to provide valuable information about an individual's risk of experiencing a near-term heart attack or stroke," said Eric Bouvier, President and CEO of BG Medicine. "There is a critical need for a simple and easy-to-use blood test to more accurately determine a patient's risk for these types of catastrophic events."

About The CardioSCORE(TM) Test

The CardioSCORE test is a proprietary blood test that measures the levels of several protein biomarkers and integrates the results to yield a single numerical score that is related to an individual's risk for near-term major cardiovascular events. The CardioSCORE test is not yet commercially available and is currently under development in the United States.

About the BioImage Study

See original here:

BG Medicine Announces Data Analyses Presented at American Heart Association Meeting

Research and Markets: Personalized Medicine Partnering Terms and Agreements

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/jm477c/personalized) has announced the addition of the "Personalized Medicine Partnering Terms and Agreements" report to their offering.

Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

The Personalized Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This report contains over 1500 links to online copies of actual personalized medicine deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Report scope

Personalized Medicine Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to personalized medicine trends and structure of deals entered into by leading companies worldwide.

Personalized Medicine Partnering Terms and Agreements includes:

Original post:

Research and Markets: Personalized Medicine Partnering Terms and Agreements

BG Medicine, Inc. to Present at Lazard Capital Markets 9th Annual Healthcare Conference

WALTHAM, Mass., Nov. 9, 2012 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Eric Bouvier, BG Medicine's President and CEO, will present at the Lazard Capital Markets 9th Annual Healthcare Conference on November 14 at 3:00 PM Eastern Time (ET) in New York City.

To access the live and subsequently archived webcast of the presentation, go to the "Investors" section of the Company's website at http://investor.bg-medicine.com/events.cfm. Replays will be available on the Company's website for 30 days after the initial presentation.

About BG Medicine, Inc.

BG Medicine, Inc. (BGMD) is a life sciences company focused on the discovery, development and commercialization of novel cardiovascular diagnostics to address significant unmet medical needs, improve patient outcomes and reduce healthcare costs. The Company's first commercialized product, the BGM Galectin-3(R) test for use in patients with chronic heart failure, is available in the United States and Europe. BG Medicine is also developing the CardioSCORE(TM) test, a blood test designed to aid in the assessment of an individual's risk for near-term major cardiovascular events. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit http://www.bg-medicine.com and http://www.galectin-3.com.

The BG Medicine Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10352

See the rest here:

BG Medicine, Inc. to Present at Lazard Capital Markets 9th Annual Healthcare Conference

Transplantation: The Art of the Possible – Video


Transplantation: The Art of the Possible
A talk by Laurence A. Turka, MD, Professor of Medicine, Harvard Medical School; Co-Director, Harvard Institute of Translational Immunology. Moderated by Freda C. Lewis-Hall, MD, DFAPA, Executive Vice President and Chief Medical Officer, Pfizer, and member of the HMS Board of Fellows. Harvard Medical School MED-EDs are a series of short, thought-provoking presentations by renowned HMS faculty, alumni, and leadership volunteers built to share and inspire new ideas.From:harvardmedicalschoolViews:17 1ratingsTime:15:12More inScience Technology

Originally posted here:

Transplantation: The Art of the Possible - Video

Sleep Deficit: The Performance Killer – Video


Sleep Deficit: The Performance Killer
A talk by Charles A. Czeisler, MD, PhD, FRCP, Baldino Professor of Sleep Medicine and Director, Division of Sleep Medicine, Harvard Medical School; Chief, Division of Sleep Medicine, Brigham and Women #39;s Hospital. Moderated by Freda C. Lewis-Hall, MD, DFAPA, Executive Vice President and Chief Medical Officer, Pfizer, and member of the HMS Board of Fellows. Harvard Medical School MED-EDs are a series of short, thought-provoking presentations by renowned HMS faculty, alumni, and leadership volunteers built to share and inspire new ideas.From:harvardmedicalschoolViews:8 1ratingsTime:13:04More inScience Technology

See the original post here:

Sleep Deficit: The Performance Killer - Video

Medicine’s Missing Measure – Video


Medicine #39;s Missing Measure
A talk by Juan Enriquez, Managing Director, Excel Venture Management. Harvard Medical School MED-EDs are a series of short, thought-provoking presentations by renowned HMS faculty, alumni, and leadership volunteers built to share and inspire new ideas.From:harvardmedicalschoolViews:0 1ratingsTime:29:24More inScience Technology

See the original post here:

Medicine's Missing Measure - Video

The Science of the Perfect Storm [10-31-2012] – Video


The Science of the Perfect Storm [10-31-2012]
Click MeTee.com and buy a Tee-Shirt using the link above for a 2% discount. MeTee: Tee-Shirt Design in Seconds. - Ezekiel #39;Zeke #39; Jonathan Emanuel (born 1957) is an American bioethicist and fellow at the nonprofit bioethics research institute The Hastings Center. He opposes legalized euthanasia, and is a proponent of a voucher-based universal health care. Before joining the NIH in 1998 he was an associate professor at the Harvard Medical School, and as of September 2011 he serves as the Diane and Robert Levy University Professor at the University of Pennsylvania, where he holds a joint appointment at the University of Pennsylvania School of Medicine and the Wharton School. Emanuel is the son of Benjamin M. Emanuel and Marsha (Smulevitz) Emanuel, and is a divorced father of three daughters. His two younger brothers are Chicago mayor Rahm Emanuel and Hollywood-based talent agent Ari Emanuel. He has an adopted sister, Shoshana Emanuel. His father #39;s brother, Emanuel, was killed in the 1936 Arab Riots in the British Mandate of Palestine, after which the family changed its name from Auerbach to Emanuel in his honor. - Subscribe for Breaking News. Like/Dislike, Comment, Favorite and share on Twitter, Facebook, and Google+ to get the word out on this video. Like on Facebook for videos in your newsfeed: http://www.facebook.com Become a channel sponsor for 30 days for $1/day and send me a private message. Have any ad you want to play at the end of each video (any one video can go viral ...From:SimplyBestNews2013Views:0 0ratingsTime:04:22More inNews Politics

See more here:

The Science of the Perfect Storm [10-31-2012] - Video

Julian Martinez MDPC Video | Medical Services in Arlington – Video


Julian Martinez MDPC Video | Medical Services in Arlington
arlington.wusa9.com We are an Ob Gyn practice dedicated to making a positive difference in the lives of women of all ages by providing individualized, compassionate and expert health care. We are up to date with the latest techniques and technology in our field and provide a more sensitive and personal approach to obstetrics and gynecology. Born in Iowa, raised in Argentina, Chile, Mexico and El Salvador, Julian Martinez attended medical school at the University of Buenos Aires, where he also began his teaching career lecturing junior medical students on gross anatomy. After graduating in 1996, he began his obstetrics and gynecology training at the "Hospital Antartida" in downtown Buenos Aires and transferred after two years to the "Hospital Ostaciana B. de Lavignolle" in the western suburbs of the same city, where he also spent one year as an attending, caring for the uninsured and underserved. He returned to the US In 2002, revalidated his medical degree in less than one year and was accepted as an ob and gyn resident at the Georgetown University Medical Center, where he also continued his teaching career and won numerous awards. After finishing residency, he worked at Arlington Women #39;s Center for one year, spent another year in the Fairfax area and moved back to Arlington where he started his own practice. Even though his main interest is minimally invasive surgery, Dr Martinez continues to enjoy all aspects of obstetrics and gynecology. 12548764 Gynecology, Robotic ...From:DataSphereVideosViews:2 0ratingsTime:00:35More inPeople Blogs

Visit link:

Julian Martinez MDPC Video | Medical Services in Arlington - Video

Lecture 26. Self-Strangulation Versus Play – Video


Lecture 26. Self-Strangulation Versus Play
Jim Gustafson, Professor of Psychiatry at the University of Wisconsin Medical School, giving his Twenty-Sixth Lecture in a series of Thirty-Six Lectures on Maps in Psychiatry, as every Friday (but for an occasional vacation week), posted mid-afternoon on YouTube -- type in Jim Gustafson Channel -- or on his web site at http: //psychiatry.wisc.edu/gustafson. Also, the new book, from which these lectures are drawn into ten-to-fifteen minute form, is available with one click also on his web site electronically. These YouTube Lectures are for doctors and psychotherapists and patients and everyone interested in maps of the whole situation that will save us, distinguished from maps captured by only a part of the situation that can snare us. They become a new sub-specialty of psychiatry, different from the main paradigm that has become more like internal medicine, useful as that is, but more like obstetrics as a set of capacities for delivering the patients from their maps of part of a situation that ensnare them. William James called it a second birth and Michael Balint called it a new beginning. My week-long Symposium at the Door County Summer Institute will be next August 5-9, 2013 on this very subject for psychotherapists and doctors. We begin from Breuer and Freud in Studies on Hysteria in 1895 writing that the accurate diagnosis for almost all of their patients is self-strangulation -- that is, choking off one #39;s own voice -- and demonstrating it in five cases. I in 2012 in ...From:Jim GustafsonViews:1 0ratingsTime:18:32More inEducation

Read more from the original source:

Lecture 26. Self-Strangulation Versus Play - Video

Laurence Lewin – Dragonfly Interview 2007 – Video


Laurence Lewin - Dragonfly Interview 2007
Here is Laurence #39;s Dragonfly interview and his CBC Dragons #39; Den bio, "Laurence is a savvy numbers man who brings flare and style to every balance sheet. Early in his career, he was removed from medical school and started his career in the then fledgling computer industry. But in the swinging #39;70s, he immigrated to Montreal, a European-style city and eventually set his eyes on the fashion industry." ideas Vacuum Producer, Director: Kempton LamFrom:Kempton LamViews:0 0ratingsTime:03:52More inFilm Animation

Follow this link:

Laurence Lewin - Dragonfly Interview 2007 - Video

Ode to a Spirit – Video


Ode to a Spirit
The first medical school in Alabama was built in the mid 1800 #39;s. It was located in Mobile, Alabama on Saint Anthony Street. Today it is still an active school which may have a little more spirit than most. It was named for poet Paul L.Dunbar.From:beyondsight1Views:6 1ratingsTime:03:08More inEntertainment

Read the original post:

Ode to a Spirit - Video

Sergei: Bio Sci – Video


Sergei: Bio Sci
Sergei is a third year Biological Sciences major with an emphasis on NPB. He is planning on going to medical school after graduating and is part of a pre-medical fraternity. He has had several research and hospital internships. The theme of this video is "It #39;s not what you know, it #39;s who you know".From:ucdstemhubViews:1 0ratingsTime:10:16More inPeople Blogs

Go here to read the rest:

Sergei: Bio Sci - Video

Momentum Pathfinder – Video


Momentum Pathfinder
Get a great deal here redirect.viglink.com?key=1f0527e04637dcdb26bf99b11836bfbf out=http%3A%2F%2Fwww%2Eamazon%2Ecom%2Fdp%2FB000PDFSOK Customer Reviews "When I started medical school, I started washing my hands many times daily. I decided to get a dive watch after, well, drowning two watches. I have now had this watch for 9 years and it is amazing. I have sent it to the factory twice for a new battery and whatever other regular maintenance that they do, for which they charged me 40 each time. Service has been excellent. If I outlive this watch, I #39;ll get another one. Very high quality and accurate time. Still looks great, too. Highly recommended." "I bought this watch for my wife about a year ago. She wears it everyday and reports that the watch is both comfortable, durable, and reliable. She is a school teacher, and as such she wanted something that would survive an elementary classroom but would also look nice.A nice feature of this watch is that it has an alarm, a rare feature on an analog watch.I high recommend this watch, as well as other watches made by St. Moritz." "This watch is unique in that it is a dressy sports watch that also has an alarm. We were a little disappointed by the color when it came in. The pics (from my computers) make it look a little brighter in color that it is in person. It is almost grey or lead in color, and not muted silver." Product Description Momentum Pathfinder Momentum #39;s Pathfinder for women is a classically designed timepiece that ...From:keena bradfordViews:0 0ratingsTime:00:54More inSports

Visit link:

Momentum Pathfinder - Video

Biotech industry will grow with new medical school – Video


Biotech industry will grow with new medical school
The new medical school coming to Austin could create some positive side effects for the local biotechnology industry -- 55 percent of voters approved paying higher taxes to help fund the University of Texas Medical School.From:kxanViews:0 0ratingsTime:02:04More inEntertainment

Read the original post:

Biotech industry will grow with new medical school - Video

Translational research par excellence – From molecules to diseases of clot stabilization – Video


Translational research par excellence - From molecules to diseases of clot stabilization
Lszl Lrnd - Northwestern University, Feinberg Medical School, Chicago, IL. 60611 European Thrombosis Research Organization International Factor XIII Workshop Debrecen, Hungary, 2012From:debreceniegyetemViews:1 0ratingsTime:29:03More inEducation

Read more here:

Translational research par excellence - From molecules to diseases of clot stabilization - Video

Sufing St. Kitts


Sufing St. Kitts Nevis in Caribbean, West Indies 1/2 - Hurricane Omar
After hurricane Omar in St. Kitts Nevis, which is where I attended medical school, I went out and surfed little bit. St. Kitts Nevis is a small country in the Caribbean, West Indies. The conditions weren #39;t enormous, and the waves didn #39;t have great form, but it was nice to actually have some swells develop and give me a break from studying.From:mkbrennan13Views:0 0ratingsTime:00:23More inTravel Events

See original here:

Sufing St. Kitts

Macadam Cup – Wiki Article – Video


Macadam Cup - Wiki Article
The Macadam Cup is a varsity match played between the sports teams of King #39;s College London proper (KCL) and King #39;s College London Medical School (KCLMS). The championship is named in honor of Sir Iv... Macadam Cup - Wiki Article - wikiplays.org Original @ http All Information Derived from Wikipedia using Creative Commons License: en.wikipedia.org Author: E01 Image URL: en.wikipedia.org ( Creative Commons ASA 3.0 )From:WikiPlaysViews:0 0ratingsTime:02:53More inEducation

Link:

Macadam Cup - Wiki Article - Video